StockDuty ← Dashboard Aug 03, 2026 06:21 PM ET
CatalystDerivatives

KRYSTAL BIOTECH OUTLINES $175M-$195M 2026 NON-GAAP OPEX RANGE AS VYJUVEK EXPANDS OVERSEAS PRICING TALKS - SEEKINGALPHA

KRYSTAL BIOTECH OUTLINES $175M-$195M 2026 NON-GAAP OPEX RANGE AS VYJUVEK EXPANDS OVERSEAS PRICING TALKS - SEEKINGALPHA

Sources